Primary information |
---|
CancerPPD ID | 4338 |
PMID | None |
YEAR | 2009 |
SEQUENCE | YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK |
LENGTH | 32 |
NAME | EB-Lytic |
C-ter Modification | Free |
N-ter Modification | Free |
Linear/Cyclic | Linear |
L/D/Mix | Mix |
Non-Natural | None |
NATURE | Anticancer |
ACTIVITY | IC50= 12 µM |
SOURCE | Synthetic Peptide |
Cancer Type | Pancreatic Cancer |
ASSAY | WST-1 assay |
Patent ID | US_8436137_B2 |
Tissue | Pancreatic |
CELL LINE | BxPC-3 |
TEST TIME | Not Available |
Secondary information |
---|
STRUCTURE | |
DSSP states | CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC |
SMILES | N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O |
External Links |
---|
PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
NA | NA | NA | NA | NA | NA | NA | NA |
|